Investors with a lot of money to spend have taken a bearish stance on AbbVie (NYSE: ABBV).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ABBV, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 11 uncommon options trades for AbbVie.
This isn't normal.
The overall sentiment of these big-money traders is split between 45% bullish and 54%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $807,896, and 2 are calls, for a total amount of $67,330.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $160.0 to $220.0 for AbbVie over the recent three months.
Insights into Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for AbbVie's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale activity within a strike price range from $160.0 to $220.0 in the last 30 days.
AbbVie Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | PUT | TRADE | BEARISH | 01/15/27 | $12.95 | $12.65 | $12.85 | $190.00 | $321.2K | 391 | 2 |
| ABBV | PUT | SWEEP | BEARISH | 01/16/26 | $11.5 | $11.25 | $11.5 | $220.00 | $105.8K | 891 | 101 |
| ABBV | PUT | TRADE | BEARISH | 11/21/25 | $5.0 | $4.95 | $5.0 | $210.00 | $86.5K | 1.5K | 570 |
| ABBV | PUT | SWEEP | BEARISH | 12/19/25 | $9.8 | $9.65 | $9.8 | $220.00 | $83.3K | 581 | 246 |
| ABBV | PUT | TRADE | BEARISH | 05/15/26 | $8.15 | $7.95 | $8.15 | $195.00 | $60.3K | 31 | 74 |
About AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Following our analysis of the options activities associated with AbbVie, we pivot to a closer look at the company's own performance.
Present Market Standing of AbbVie
- Trading volume stands at 2,435,721, with ABBV's price up by 0.87%, positioned at $220.44.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 33 days.
What Analysts Are Saying About AbbVie
In the last month, 5 experts released ratings on this stock with an average target price of $247.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on AbbVie with a target price of $240. * An analyst from Cantor Fitzgerald persists with their Overweight rating on AbbVie, maintaining a target price of $245. * Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on AbbVie with a target price of $260. * An analyst from Evercore ISI Group has decided to maintain their Outperform rating on AbbVie, which currently sits at a price target of $222. * An analyst from Berenberg has elevated its stance to Buy, setting a new price target at $270.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AbbVie, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
